ELUCENIA
Skip to content
ELUCENIA

ELUCENIA / Cancer atlas

Bladder cancer

Muscle invasion, recurrence and progression are essential distinctions when studying bladder tumors.

Editorial update · October 6, 2026

Context and biological diversity

Non-muscle-invasive bladder cancer and muscle-invasive disease have different trajectories and research questions. Histology, grade, depth of invasion and previous treatments should accompany the data. Recurrence of a lesion and progression to a more advanced category need separate definitions.

What research makes it possible to study

TCGA characterized muscle-invasive bladder cancer through genomics and expression, demonstrating molecular diversity. The dataset supports exploration of groupings and altered pathways in this setting. It does not automatically represent non-muscle-invasive tumors, and observed groups do not replace pathological and clinical classification.

Application in a research project

A longitudinal project can integrate reports, procedures and serial samples, recording how each recurrence was confirmed. When comparing treatments in registries, differences in stage and clinical selection can cause confounding. Urinary biomarker assessment should include inconclusive tests and conditions that may interfere with the result.

Research questions

Does a urinary marker distinguish confirmed recurrence from absence of recurrence in a defined follow-up population?

Study design
A prospective accuracy study with collection before the reference procedure and blinded interpretation.
What to measure
Sensitivity, specificity, inconclusive results and performance by grade and invasion.
Interpretation limits
Diagnostic performance does not show that replacing examinations improves outcomes. Do not combine recurrence, progression and death into one event without detailing its components.

Interpretation limits

Diagnostic performance does not show that replacing examinations improves outcomes. Do not combine recurrence, progression and death into one event without detailing its components.

Original references

  1. Bladder Cancer Treatment (PDQ®)–Health Professional Version
  2. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
  3. NCI · Bladder cancer

Continue exploring

Educational content for framing research. Consult the original document, study population and methodology before interpreting a conclusion. Methodology

What would you like to understand?

Search brings together public editorial content and tools. Results retain their review status.